SinfoniaRx Revenue and Competitors

Tucson, AZ USA

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • SinfoniaRx's estimated annual revenue is currently $22.4M per year.(i)
  • SinfoniaRx's estimated revenue per employee is $270,000

Employee Data

  • SinfoniaRx has 83 Employees.(i)
  • SinfoniaRx grew their employee count by -55% last year.

SinfoniaRx's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.3M28-10%N/AN/A
#2
$10.2M474%N/AN/A
#3
$16.5M68-1%N/AN/A
#4
$5.5M29-3%N/AN/A
#5
$9.9M462%N/AN/A
#6
$6.7M310%N/AN/A
#7
$4.5M240%N/AN/A
#8
$15.3M637%N/AN/A
#9
$815.8M211320%$7.5MN/A
#10
$156.3M4637%N/AN/A
Add Company

What Is SinfoniaRx?

SinfoníaRx, a Tabula Rasa HealthCare Company, is an industry leading provider of Medication Therapy Management (MTM) services. Through a comprehensive suite of innovative healthcare solutions, SinfoníaRx provides direct support to health plans, health systems, provider organizations, and pharmacies. SinfoníaRx’s staff of nationally renowned clinical pharmacists, pharmacy interns, pharmacy technicians and interprofessional team work directly with caregivers, patients, and providers to ensure the most effective and safest medication therapy possible.\n\nRxCompanion™, an award-winning proprietary software platform, serves as the driver behind SinfoníaRx’s programs and outcomes. A highly customizable and scalable platform, RxCompanion™ is designed to identify and resolve medication and other health related problems through a population management approach. Since inception, SinfoníaRx has generated over $1 billion in total healthcare savings and now serves 50 million patients nationwide, or 1 in every 7 Americans.\n\nwww.sinfoniarx.com

keywords:N/A

N/A

Total Funding

83

Number of Employees

$22.4M

Revenue (est)

-55%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.1M8320%N/A
#2
$17.4M8354%N/A
#3
$20.8M832%N/A
#4
$18.3M83-3%N/A
#5
$14.9M83-3%N/A